6.35
-0.22(-3.35%)
Currency In USD
| Previous Close | 6.57 |
| Open | 6.52 |
| Day High | 6.74 |
| Day Low | 6.25 |
| 52-Week High | 3,756 |
| 52-Week Low | 5.11 |
| Volume | 25,963 |
| Average Volume | 948,911 |
| Market Cap | 3.6M |
| PE | 0 |
| EPS | -3,442.8 |
| Moving Average 50 Days | 7.14 |
| Moving Average 200 Days | 352.49 |
| Change | -0.22 |
If you invested $1000 in GlucoTrack, Inc. (GCTK) 10 years ago, it would be worth $0.02 as of July 30, 2025 at a share price of $6.35. Whereas If you bought $1000 worth of GlucoTrack, Inc. (GCTK) shares 5 years ago, it would be worth $0.27 as of July 30, 2025 at a share price of $6.35.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Glucotrack Announces Repurchase of Series A Warrants
GlobeNewswire Inc.
Jul 08, 2025 12:30 PM GMT
Warrant buyback extinguishes warrant liability accounting and share dilution overhangRUTHERFORD, N.J., July 08, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercializa
Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
GlobeNewswire Inc.
Jun 25, 2025 12:30 PM GMT
Comprehensive analysis confirms safety and strong accuracy of Glucotrack's innovative blood-based continuous glucose monitoring technology, with MARD of 7.7%RUTHERFORD, N.J. and STOCKHOLM, June 25, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq:
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements
GlobeNewswire Inc.
Jun 12, 2025 1:05 PM GMT
1-for-60 reverse stock split to become effective as of the opening of trading on June 16, 2025 Rutherford, NJ, June 12, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused o